Continuing C3 breakdown after bilateral nephrectomy in patients with membrano-proliferative glomerulonephritis. - Wikidata - wikimedia - TriplyDB

Continuing C3 breakdown after bilateral nephrectomy in patients with membrano-proliferative glomerulonephritis.

Continuing C3 breakdown after bilateral nephrectomy in patients with membrano-proliferative glomerulonephritis.

http://www.wikidata.org/entity/Q34057909

about

Hypocomplementemia of membranoproliferative nephritis. Dependence of the nephritic factor reaction on properdin factor B.Hypocomplementaemic membranoproliferative glomerulonephritis and nephrotic syndrome associated with partial lipodystrophy of the face and trunk.The immunological basis of glomerulonephritis.C3 glomerulopathy: a new classification.Complement and the kidney A serum factor in chronic hypocomplementemic hephritis distinct from immunoglobulins and activating the alternate pathway of complement.All Things Complement.

P2860

Q34502559-C0495359-6CA4-4783-96A8-10117B3C810A Q35142386-4EC34658-062E-4967-A512-0CCC50568A58 Q35144909-072CCFA7-D5C6-4072-BA53-F6B28F6C05DB Q37770399-9B23BC46-9FCB-4A85-8F2E-903EE9B5D87C Q39385277-30AD1566-89FA-4FF7-ADEF-7F8E096D4940 Q41882579-B6686F08-8402-4A1D-A4D5-243801C50687 Q42386506-D0A04AB0-ED71-4180-BE7F-89730A96D1A9

P2860

Continuing C3 breakdown after bilateral nephrectomy in patients with membrano-proliferative glomerulonephritis.

http://www.wikidata.org/entity/Q34057909

description

1971 nî lūn-bûn

@nan

1971 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

1971 թվականի մարտին հրատարակված գիտական հոդված

@hy

1971年の論文

@ja

1971年論文

@yue

1971年論文

@zh-hant

1971年論文

@zh-hk

1971年論文

@zh-mo

1971年論文

@zh-tw

1971年论文

@wuu

name

Continuing C3 breakdown after ...... liferative glomerulonephritis.

@ast

Continuing C3 breakdown after ...... liferative glomerulonephritis.

@en

Continuing C3 breakdown after ...... liferative glomerulonephritis.

@nl

type

label

Continuing C3 breakdown after ...... liferative glomerulonephritis.

@ast

Continuing C3 breakdown after ...... liferative glomerulonephritis.

@en

Continuing C3 breakdown after ...... liferative glomerulonephritis.

@nl

prefLabel

Continuing C3 breakdown after ...... liferative glomerulonephritis.

@ast

Continuing C3 breakdown after ...... liferative glomerulonephritis.

@en

Continuing C3 breakdown after ...... liferative glomerulonephritis.

@nl

P1433

Q34057909-0142061F-D07A-4045-81F3-522EE58D614A

P1476

Q34057909-89864078-FC07-4E37-BFA6-8B717E01FCC9

P2093

Q34057909-5D6213AA-097E-445D-87AF-4498375F7383

Q34057909-66D0D14E-6DE2-4C20-912B-E791154D1735

Q34057909-78D96E33-F578-45CD-97C0-B90607A7C923

Q34057909-C9FF3DB1-A7A1-417F-B47D-661AD1E1AED3

Q34057909-DA279099-F2FF-434A-9DA7-651E5DA54E36

P2860

Q34057909-02506942-3963-48BB-AD4B-A76532B0929D

Q34057909-1CA1D318-6ED4-45C4-B1D6-791C5AD176E4

Q34057909-2F7F5804-29C6-44DB-891A-FDC5CAA23B9E

Q34057909-3745B01D-EEB6-4462-ACFE-BF85ED18D960

Q34057909-495C61BB-3F29-4E1C-9CFA-46B11E1330EF

Q34057909-6642E7D7-1537-4AAF-A9C2-4E40E87994A5

Q34057909-726DF94B-32FC-4DFD-942C-379020CDB313

Q34057909-7AD30C2B-4E5B-4317-A4F3-2041E2DA7F33

Q34057909-82F1E5EE-52A8-4B31-93C5-E816057E20AA

Q34057909-860F33FE-29B2-40E0-8E76-1BBB89281F4E

P304

Q34057909-3924DB36-A5F0-4480-995A-D514E8AA5F4B

P31

Q34057909-4165E872-9AD1-41BA-8A6F-F51563E69752

P356

Q34057909-5A6D11F2-BE4D-4679-BBA7-80291EC5D066

P407

Q34057909-1B293820-1C98-4AF6-833F-16D8D68FBF79

P433

Q34057909-B6113174-D79B-47E6-8044-CC7ED9500B41

P478

Q34057909-47371615-2031-4498-A0CD-62ECDB4410D4

P577

Q34057909-B115D4A4-7619-4F86-931C-21152C2CBE09

P5875

Q34057909-4556A09C-8EB3-4F9E-A6E5-611BC810C1AE

P698

Q34057909-09E9AEA0-B45C-434C-B3E0-CF475D4D4811

P921

Q34057909-C4C88432-2393-4E1F-8B59-CFFA99F86F9E

P932

Q34057909-79706AAC-24EE-45FD-81F1-5EF169123A1C

P356

P1433

Journal of Clinical Investigation

P1476

Continuing C3 breakdown after ...... liferative glomerulonephritis.

@en

P2093

Davis NC

http://www.w3.org/2001/XMLSchema#string

Forristal J

http://www.w3.org/2001/XMLSchema#string

Spitzer RE

http://www.w3.org/2001/XMLSchema#string

Vallota EH

http://www.w3.org/2001/XMLSchema#string

West CD

http://www.w3.org/2001/XMLSchema#string

P2860

Alper CA, Rosen FS: Studies of the in vivo behavior of human C'3 in normal subjects and patients.

IMMUNOLOGIC BASIS OF RENAL DISEASE.

SERUM LEVELS OF BETA-1C GLOBULIN, A COMPLEMENT COMPONENT, IN THE NEPHRITIDES, LIPOID NEPHROSIS, AND OTHER CONDITIONS.

Evidence for in vivo breakdown of beta-10-globulin in hypocomplementemic glomerulonephritis

Acute serum sickness nephritis in the rabbit. An immune deposit disease

Experimental hypersensitivity in the rabbit; effect of inhibition of antibody formation by X-radiation and nitrogen mustards on the histologic and serologic sequences, and on the behavior of serum complement, following single large injections of for

A ROLE OF POLYMORPHONUCLEAR LEUKOCYTES AND COMPLEMENT IN NEPHROTOXIC NEPHRITIS.

ISOLATION OF BETA IF-GLOBULIN FROM HUMAN SERUM AND ITS CHARACTERIZATION AS THE FIFTH COMPONENT OF COMPLEMENT.

The derivation of two distinct anaphylatoxin activities from the third and fifth components of human complement.

Isolation of a fragment (C3a) of the third component of human complement containing anaphylatoxin and chemotactic activity and description of an anaphylatoxin inactivator of human serum.

P304

552-558

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI106524

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

50

http://www.w3.org/2001/XMLSchema#string

P577

1971-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

18066613

http://www.w3.org/2001/XMLSchema#string

P698

5101779

http://www.w3.org/2001/XMLSchema#string

P921

glomerulonephritis

P932

291962

http://www.w3.org/2001/XMLSchema#string